The Trump administration expanded its direct-to-consumer drug sales website, TrumpRx, on Monday by adding more than 600 generic medications to the platform, along with new tools designed to help patients find the lowest available prices on their prescriptions.
President Donald Trump announced the additions at an event on Monday, where executives from several partnering companies were also present. The administration said it is working with Mark Cuban's Cost Plus Drug Co., Amazon Pharmacy, and GoodRx, all of which have been selling medications directly to consumers at transparent prices.
"By incorporating this massive catalog of low-cost generics at TrumpRx.gov, consumers will now have one source to ensure that they're getting the lowest possible cost on their prescription, so they have a real option now, today," Trump said.
According to CNBC, TrumpRx launched in February and initially offered select branded products from manufacturers that struck deals with the administration to voluntarily lower prices for American consumers. That included blockbuster obesity drugs from Eli Lilly and Novo Nordisk. Until Monday's expansion, generic medications were not part of the platform.
Trump also claimed at the event that the site has been visited more than 10 million times and has already saved Americans more than $400 million.
The new tools added to the platform include a feature that identifies the pharmacy with the lowest prices in a patient's neighborhood, as well as an option for home delivery of prescriptions. The site functions as a central hub, directing users to drugmakers offering discounts through their own direct-to-consumer platforms or providing discount coupons that patients can bring to pharmacies. The site does not sell drugs directly to patients.
One key limitation of the platform involves patients who carry insurance. It remains unclear whether insured patients would save more money using TrumpRx than through their existing coverage. The site appears to primarily target patients who are willing to pay with cash and skip their insurance, meaning those without coverage or with limited coverage may benefit the most from using it.
The expansion represents one of the more visible moves by the administration in its broader effort to drive down prescription drug costs in the United States.
